Your activity: 34 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Micronutrient management after bariatric surgery[1]

Micronutrient management after bariatric surgery[1]
  Preoperative prevalence Postoperative prevalence Symptoms of deficiency RDA[2] Supplementation Repletion
Vitamin A[1,3] Up to 17%[3]

8 to 11% after RYGB

70% after BPD/DS
Early signs:
  • Night blindness
  • Bitot's spots
  • Hyperkeratinization of skin
  • Loss of taste

Advanced signs:
  • Corneal damage
  • Blindness

Men: 900 mcg (3000 IU)

Women: 700 mcg (2300 IU)

LAGB: 5000 IU daily

RYGB or SG: 5000 to 10,000 IU daily

BPD/DS: 10,000 IU daily

Without corneal changes: 10,000 to 25,000 IU daily orally until clinical improvement (1 to 2 weeks)

With corneal changes: 50,000 to 100,000 IU daily IM for 3 days, followed by 50,000 IU daily IM for 2 weeks
Vitamin D 25 to 68% 25 to 80% Hypocalcemia, tetany, tingling, cramping, metabolic bone disease, muscle pain

General: 600 IU

Pregnancy, lactation, or over 71 years of age: 800 IU

3000 IU D3 daily from all sources to maintain a 25(OH)D level of >30 ng/mL 3000 to 6000 IU of D3 daily (preferred), or 50,000 IU of D2 1 to 3 times per week
Vitamin E 2.2% Uncommon Neuromuscular disorders and hemolysis

General: 15 mg (22.4 IU)

Lactation: 19 mg (28.4 IU)

Adults and adolescents 14 or older: 15 mg (22.4 IU) daily

Lactation: 19 mg (28.4 IU) daily

90 to 300 mg (100 to 400 IU) daily
Vitamin K Uncommon Uncommon Impaired coagulation 90 to 120 mcg

LAGB, RYGB, or SG: 90 to 120 mcg daily

BPD/DS: 300 mcg daily

Acute malabsorption: 10 mg of parenteral vitamin K

Chronic malabsorption: 1 to 2 mg per day orally or 1 to 2 mg per week parenterally

Vitamin B1 (Thiamine) 16 to 29% 1 to 49%

Numbness, tingling in extremities, gait ataxia, edema, vomiting, confusion

Wernicke-Korsakoff syndrome:
  • Encephalopathy
  • Ataxia
  • Oculomotor dysfunction
  • Confabulation
  • Impaired memory
  • Impaired learning

Beriberi:
  • Neuropathy
  • Pain
  • Paresthesia
  • Loss of reflexes
1.5 mg

>12 mg daily, preferably 50 to 100 mg daily from a B-complex supplement

With IV hydration, 100 mg of thiamine should be added to the solution (should not contain glucose if Wernicke encephalopathy is suspected)

Oral: 100 mg two to three times daily until symptoms resolve

Intravenous: 200 mg three times daily to 500 mg once or twice daily for 3 to 5 days, followed by 250 mg daily for 3 to 5 days, and subsequent oral maintenance (100 mg daily) indefinitely

Intramuscular: 250 mg daily for 3 to 5 days, or 100 to 250 mg monthly
Vitamin B12 0 to 18% 33% after RYGB; 4 to 20% after SG Macrocytic (megaloblastic) anemia, mild pancytopenia, neuropsychiatric findings (eg, depression, neuropathy) 2.4 mcg Oral dose of 350 to 1000 mcg daily, or 1000 mcg IM or SQ monthly, or by nasal spray 1000 mcg daily until the level is normalized, then resume maintenance dose
Folate 0 to 54% Up to 65% after RYGB; 18% after SG Macrocytic (megaloblastic) anemia, mild pancytopenia, neural tube defects 400 mcg

General: 400 to 800 mcg daily from multivitamin

Women of childbearing age: 800 to 1000 mcg daily

Should not exceed 1 mg per day

Oral dose of 1000 mcg daily until the level is normalized, then resume maintenance dose
Iron 0 to 58% LAGB 14%, SG <18%, RYGB 20 to 55%, BPD 13 to 62%, DS 8 to 50%

Anemia

Pica

Impaired learning

Men ages 19 and older and women ages 51 and older: 8 mg per day

Women between the ages of 19 to 50: 18 mg per day

Males, post-menopausal women, and patients without history of anemia: 18 mg of iron from a multivitamin

Menstruating women and men or women who have undergone RYGB, SG, or BPD/DS: >45 to 60 mg of elemental iron daily from all sources*

Oral: 150 to 300 mg 2 to 3 times a day

Parenteral iron for those who do not respond to oral supplementation

Zinc 24 to 28% overall; 9 to 74% seeking BPD/DS 70% after BPD/DS, 40% after RYGB, 19% after SG, 34% after LAGB Growth retardation, delayed sexual maturity, impotence, impaired immune function

Women: 8 mg

Men: 11 mg

BPD/DS: 16 to 22 mg (200% RDA)

RYGB: 8 to 22 mg (100 to 200% RDA)

SG or LAGB: 8 to 11 mg (100% RDA)

Maintain a ratio of 8 to 15 mg of zinc per 1 mg of copper

Optimal repletion dose unknown

Overdose can be associated with toxicity or copper deficiency
Copper 68% in women seeking BPD 90% after BPD/DS, 10 to 20% after RYGB Anemia, neutropenia, ataxia 900 mcg

BPD/DS or RYGB: 2 mg daily (200% RDA)

SG or LAGB: 1 mg daily (100% RDA)

Maintain a ratio of 8 to 15 mg of zinc per 1 mg of copper

Mild-to-moderate deficiency: 3 to 8 mg copper orally until levels normalize

Severe deficiency: 2 to 4 mg intravenous copper for 6 days or until symptoms resolve
Selenium 2% 14 to 22% after RYGB and BPD/DS Skeletal muscle dysfunction and cardiomyopathy, mood disorder, impaired immune function, macrocytosis 55 mcg Unknown but likely higher than 100 mcg/day[4] 2 mcg/kg/day in patients who develop cardiomyopathy[5]
Calcium 1 to 10%[6] 3.6% after bariatric surgery (1.9% after RYGB, 9.3% after SG, and 10% after BPD/DS) Bone disease, secondary hyperparathyroidism 1000 to 1200 mg

RYGB, SG, or LAGB: 1200 to 1500 mg daily in divided doses

BPD/DS: 1800 to 2400 mg daily in divided doses

RYGB, SG, or LAGB: 1200 to 1500 mg daily in divided doses

BPD/DS: 1800 to 2400 mg daily in divided doses

RDA: Recommended Daily Allowance; RYGB: Roux-en-Y gastric bypass; BPD/DS: biliopancreatic diversion with duodenal switch; IU: international unit; LAGB: laparoscopic adjustable gastric band; SG: sleeve gastrectomy; IM: intramuscular; IV: intravenous; SQ: subcutaneous.
References:
  1. Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures - 2019 update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg Obes Relat Dis 2020; 16:175.
  2. U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015–2020 Dietary Guidelines for Americans, 8th Edition, December 2015. Available at: https://health.gov/our-work/food-nutrition/previous-dietary-guidelines/2015 (Accessed on April 7, 2021).
  3. Stein J, Stier C, Raab H, Weiner R. Review article: The nutritional and pharmacological consequences of obesity surgery. Aliment Pharmacol Ther 2014; 40:582.
  4. Institute of Medicine (U.S.). Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, National Academy Press, Washington DC 2000.
  5. Al-Matary A, Hussain M, Ali J. Selenium: a brief review and a case report of selenium responsive cardiomyopathy. BMC Pediatr 2013; 13:39.
  6. Shah M, Sharma A, Wermers RA, et al. Hypocalcemia after bariatric surgery: Prevalence and associated risk factors. Obes Surg 2017.
Graphic 114101 Version 5.0